DARVON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Darvon, and when can generic versions of Darvon launch?
Darvon is a drug marketed by Xanodyne Pharm and Aaipharma Llc and is included in six NDAs.
The generic ingredient in DARVON is aspirin; propoxyphene napsylate. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; propoxyphene napsylate profile page.
Summary for DARVON
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 42 |
Patent Applications: | 4,253 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DARVON at DailyMed |